Navigation Links
Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award
Date:2/5/2013

5 February 2013 EMBO and the Federation of European Biochemical Societies (FEBS) announce Genevive Almouzni, deputy director of the Institut Curie in Paris, France, as the winner of the 2013 FEBS | EMBO Women in Science Award.

Professor Almouzni has been recognized for her outstanding contributions to research in the area of histones and chromatin, her engagement in promoting epigenetics in Europe, and her active role in mentoring female scientists.

The FEBS | EMBO Women in Science Award rewards the exceptional achievements of a female researcher in molecular biology over the previous five years. Winners of the award are role models who inspire future generations of women in science.

Almouzni has investigated the basic mechanisms involved in chromatin assembly from the nucleosome to higher order structures such as those found in heterochromatin domains. The dynamics of this organization in the context of cell cycle, development as well as genotoxic stresses have been central to her research. "Her work has greatly extended our understanding of chromatin assembly and DNA repair," said Sir John Gurdon, winner of the 2012 Nobel Prize in Physiology or Medicine, who worked with the award winner on examining aspects of nuclear reprogramming involving histone variants.

"It is a great honor for all scientists who work in the field of chromatin and epigenetics, particularly for all women in science," said the award winner upon hearing of her distinction.

The French scientist has been an inspiring mentor and motivator for other women in science throughout her career at the Institut Curie. She is also highly engaged with the European scientific community as the coordinator and member of international projects such as the FP6 Epigenome Network of Excellence and the FP7 European Network of Excellence EpiGeneSys. Her publishing record encompasses more than 160 papers and she sits on numerous committees and editorial boards including the advisory editorial board of The EMBO Journal. "Her capacity to succeed at all levels and still have the time and energy for others is admirable," stated her colleague Edith Heard, Research Unit director at the Institut Curie.

The 2013 FEBS | EMBO Women in Science Award of 10,000 euros will be presented to Genevive Almouzni on 9 July at the FEBS Congress in St. Petersburg, Russia, where she will give a special lecture. Nominations for the 2014 FEBS | EMBO Women in Science Award close on 15 October 2013. For more information, please visit: http://www.embo.org/policy-and-society/women-in-science/women-in-science-award.html or http://www.febs.org/women-award.

Biosketch

Genevive Almouzni studied biology at the cole Normale Suprieure in Paris. She completed her PhD at the University of Paris 6 and started her professional career in the laboratory of Marcel Mchali, where she managed to identify critical molecular mechanisms regulating DNA replication and chromatin assembly. After completing a CNRS research assistant position in 1991, she moved to the lab of Alan Wolffe, a scientist who turned the chromatin field into a mainstream research subject. In 1994, Genevive Almouzni was awarded a junior investigator grant of the CNRS and started as a junior group leader at the Institut Curie.

She has held appointments as head of research unit and deputy director of the Institut Curie. The French scientist received the silver medal of the CNRS and became a member of the scientific advisory board of the European Molecular Biology Laboratory and Panel Member of the European Research Council (ERC). Recently, she received an ERC Advanced Investigator grant and obtained a Laboratory of Excellence grant from the French Ministry of Research. She has served as elected member of the EMBO Council since 2011.


'/>"/>

Contact: Barry Whyte
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. DigitalPersona Fingerprint Readers Receive STQC Certification for UIDAI Program in India
2. Xenon Receives a Milestone Payment for Marketing Approval of Glybera in Europe
3. Brainwave "Balancing" Research Receives $1 Million Grant From The Susanne Marcus Collins Foundation, Inc.
4. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
5. Univ. of Miami profs Chen and Soden named Fellows of AMS, Albrecht receives AMS Teaching Award
6. Childrens Hospital of Philadelphia receives federal grant to improve health care decision-making
7. Bloomberg School receives $28 million for family planning advocacy
8. UC Riverside turfgrass specialist receives high honor
9. University of Illinois receives grant to study ozone resistance in corn
10. Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB
11. CU-led team receives $9.2 million DOE grant to engineer E. coli into biofuels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/25/2016)...   Unisys Corporation (NYSE: UIS ) today announced ... International Airport, New York City , to help ... to enter the United States using passports ... pilot testing of the system at Dulles last year. The ... during January 2016. --> pilot testing of the ...
(Date:1/20/2016)... -- A market that just keeps on growing. Molecular ... in genomics knowledge. Learn all about it in this ... dynamic trends are pushing market growth and company valuations. ... - pathogen evolution - next generation sequencing - emergence ... of the role of genetic material in Disease and ...
(Date:1/13/2016)... 13, 2016 --> ... new market report titled - Biometric Sensors Market - Global ... - 2023. According to the report, the global biometric sensors market was ... to reach US$1,625.8 mn by 2023, expanding at a ... of volume, the biometric sensors market is expected to ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... 2015. --> --> For ... of $29.3 million, or $0.34 loss per share, compared to a ... the same period in 2014. For the year ended December 31, ... $1.05 loss per share, as compared to a net loss of ...
(Date:2/11/2016)... , Germany and ... -- QGEN ; Frankfurt Prime Standard: QIA) ... QIAseq Targeted RNA Panels for gene expression profiling, expanding ... sequencing (NGS). The panels enable researchers to select from ... fold changes and discover interactions between genes, cellular phenotypes ...
(Date:2/11/2016)... ATLANTA , Feb. 11, 2016  Spectra BioPharma ... Organization (CSO) that provides biopharma companies the experience, ... implement and deploy outsourced sales teams. Created in ... team addresses both the strategic and tactical needs ... innovative sales solutions through both personal and non-personal ...
(Date:2/11/2016)... , ... February 11, 2016 ... ... publication dedicated to delivering cutting-edge information focused on the development and manufacture ... to become a premier sponsor of the 2016 BioProcess International Awards – ...
Breaking Biology Technology: